Literature DB >> 16216866

Natriuretic peptides as a prognostic marker and therapeutic target in heart failure.

G A Wright, A D Struthers.   

Abstract

Natriuretic peptides may have an increasing role in assisting clinicians to target treatment in patients with chronic heart failure.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16216866      PMCID： PMC1860769          DOI： 10.1136/hrt.2003.018325

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  14 in total

1.  Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

Authors:  T Tsutamoto; A Wada; K Maeda; T Hisanaga; N Mabuchi; M Hayashi; M Ohnishi; M Sawaki; M Fujii; H Horie; Y Sugimoto; M Kinoshita
Journal:  Eur Heart J       Date:  1999-12       Impact factor: 29.983

2.  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.

Authors:  R W Troughton; C M Frampton; T G Yandle; E A Espiner; M G Nicholls; A M Richards
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

3.  Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.

Authors:  T Tsutamoto; A Wada; K Maeda; N Mabuchi; M Hayashi; T Tsutsui; M Ohnishi; M Sawaki; M Fujii; T Matsumoto; T Matsui; M Kinoshita
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

4.  Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population.

Authors:  T A McDonagh; A D Cunningham; C E Morrison; J J McMurray; I Ford; J J Morton; H J Dargie
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

5.  Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

Authors:  Inder S Anand; Lloyd D Fisher; Yann-Tong Chiang; Roberto Latini; Serge Masson; Aldo P Maggioni; Robert D Glazer; Gianni Tognoni; Jay N Cohn
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

6.  Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

Authors:  D R Murdoch; T A McDonagh; J Byrne; L Blue; R Farmer; J J Morton; H J Dargie
Journal:  Am Heart J       Date:  1999-12       Impact factor: 4.749

7.  A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

Authors:  V Cheng; R Kazanagra; A Garcia; L Lenert; P Krishnaswamy; N Gardetto; P Clopton; A Maisel
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

8.  Biochemical detection of left-ventricular systolic dysfunction.

Authors:  T A McDonagh; S D Robb; D R Murdoch; J J Morton; I Ford; C E Morrison; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

9.  B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.

Authors:  Rudolf Berger; Martin Huelsman; Karin Strecker; Anja Bojic; Petra Moser; Brigitte Stanek; Richard Pacher
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

10.  N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure.

Authors:  R S Gardner; F Ozalp; A J Murday; S D Robb; T A McDonagh
Journal:  Eur Heart J       Date:  2003-10       Impact factor: 29.983
View more
  12 in total

1.  CHA2DS2-VASc Score: A Simple But Not Appropriate Risk Score for Predicting Mortality Risk in Patients with Heart Failure.

Authors:  Chun-Li Wang
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

2.  Plasma marinobufagenin immunoreactivity in patients with chronic kidney disease: a case control study.

Authors:  Grzegorz Piecha; Agata Kujawa-Szewieczek; Piotr Kuczera; Katarzyna Skiba; Ewelina Sikora-Grabka; Andrzej Więcek
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-25

Review 3.  Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.

Authors:  Sarah Mangiafico; Lisa C Costello-Boerrigter; Ingrid A Andersen; Alessandro Cataliotti; John C Burnett
Journal:  Eur Heart J       Date:  2012-08-31       Impact factor: 29.983

Review 4.  Hypertrophic cardiomyopathy: a review.

Authors:  Brian A Houston; Gerin R Stevens
Journal:  Clin Med Insights Cardiol       Date:  2015-01-26

5.  Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.

Authors:  Sayma Sabrina Khanam; Jung-Woo Son; Jun-Won Lee; Young Jin Youn; Junghan Yoon; Seung-Hwan Lee; Jang-Young Kim; Sung Gyun Ahn; Min-Soo Ahn; Byung-Su Yoo
Journal:  BMC Cardiovasc Disord       Date:  2017-08-03       Impact factor: 2.298

6.  Serum BNP levels are associated with malignant pericardial effusion.

Authors:  Shemy Carasso; Liza Grosman-Rimon; Ali Nassar; Fabio Kusniec; Diab Ghanim; Gabby Elbaz-Greener; Wadi Kinany; Doron Sudarsky; Evgeni Hazanov; Offer Amir
Journal:  Int J Cardiol Heart Vasc       Date:  2019-04-09

7.  High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.

Authors:  Yuen-Kwun Wong; Chloe Y Y Cheung; Clara S Tang; JoJo S H Hai; Chi-Ho Lee; Kui-Kai Lau; Ka-Wing Au; Bernard M Y Cheung; Pak-Chung Sham; Aimin Xu; Karen S L Lam; Hung-Fat Tse
Journal:  Cardiovasc Diabetol       Date:  2019-12-17       Impact factor: 9.951

8.  Cardiac biomarkers in acute respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Dilip Jayasimhan; Simon Foster; Catherina L Chang; Robert J Hancox
Journal:  J Intensive Care       Date:  2021-04-26

9.  Differential effects of atrial and brain natriuretic peptides on human pulmonary artery: An in vitro study.

Authors:  Azar Hussain; Robert T Bennett; Zaheer Tahir; Emmanuel Isaac; Mubarak A Chaudhry; Syed S Qadri; Mahmoud Loubani; Alyn H Morice
Journal:  World J Cardiol       Date:  2019-10-26

10.  Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation.

Authors:  Hyun Sik Chung; AMi Woo; Min Suk Chae; Sang Hyun Hong; Chul Soo Park; Jong Ho Choi; Yun Sung Jo
Journal:  Int J Med Sci       Date:  2021-04-23       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.